Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives | Zendy

Murat Oral | Zendy; Gülbin Özçelikay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ethical Overview of Pharmaceutical Industry Policies in Turkey from Various Perspectives

Author(s) -

Murat Oral,

Gülbin Özçelikay

Publication year - 2017

Publication title -

turkish journal of pharmaceutical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.241

H-Index - 14

eISSN - 2148-6247

pISSN - 1304-530X

DOI - 10.4274/tjps.88598

Subject(s) - pharmaceutical industry , pharmacy , business , product (mathematics) , pharmacoeconomics , marketing , drug pricing , medicine , pharmacology , law , actuarial science , political science , geometry , mathematics , pathology

Countries' national drug policies include all key stakeholders (pharmacists, physicians, pharmaceutical firms, and patients) in the public, the private sector, and the field of pharmacy. The aim of this study was to outline pharmaceutical patents and data protection, orphan drugs, drug pricing, and surplus goods regarding pharmacoeconomics, promotions, inspections in the pharmaceutical industry, and policies in pharmacies with respect to buying and selling drugs, and to discuss ethics in particular.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research